← Leaderboards
Roger Allen Sabbadini
Vaxiion Therapeutics, Inc.
$106,914
Attributed
$213,828
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $144.1K · FY2013–14$200K$150K$100K$50K$0
'13
'14
Funding mix
By agency
NIH$213,828 · 1
By mechanism
R43$213,828 · 1
Top collaborators
- Matthew Giacalone2 shared
Most similar at Vaxiion Therapeutics, Inc.
Same institution · by research overlap
- Matthew Giacalone$659,317
Others in their field
Top investigators on “Adjuvant Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$265,384,749
- Norman Wolmark · Nsabp Foundation, Inc.$252,082,455
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$105,968,129
- David Heimbrook · Leidos Biomedical Research, Inc.$59,661,099
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
Adjuvant TherapyBacteriaBacterial ChromosomesBladderBladder NeoplasmCalmette-Guerin BacillusCancer PatientCellsCharacteristicsChromosomesChronicCystectomyCytokineDesignDoseDrug FormulationsEngineeringExcisionFaceFailure (Biologic Function)GuidelinesHigh RiskHistologyAcute